Rare diseases
Investigational molecules
Locations
Back to Germany390 clinical trials in Erlangen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors
GermanyStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
GermanyStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
GermanyStudy Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
GermanyStudy on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies
GermanyStudy of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive
GermanyStudy Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients
GermanyStudy on the Safety and Effects of Fasudil Hydrochloride for Patients with Parkinson's Disease
GermanyStudy on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer
GermanyStudy of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes
GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of new therapies for HR-positive and HER2-negative variants. Additional research encompasses lung cancer and various lymphomas.
Studies evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.
Comprehensive research into various autoimmune disorders, including lupus erythematosus, psoriasis, and systemic conditions. Studies focus on innovative therapeutic approaches.
Trials aim to develop more effective treatments for chronic autoimmune conditions.
Clinical investigations focusing on acute cerebral ischemic stroke and multiple system atrophy. Research emphasizes innovative therapeutic approaches for better patient outcomes.
Studies evaluate new therapeutic agents and treatment strategies for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
